Introduction
Hypokalaemia is a frequent complication associated with acute myeloid leukaemia (Muggia et al., 1969; Pruzanski and Platts, 1970; Mir et al., 1975) . Some workers (Muggia et al., 1969; Pickering and Catovsky, 1973) have attributed the hypokalaemia to raised serum concentrations of a small molecular weight protein, lysozyme (muramidase), which is elaborated by primitive white blood cells in acute myeloid leukaemia (AML). This view was questioned by Mir et al. (1975) , who carried out potassium balance studies in 32 patients with AML, and found that concentrations of serum and urinary lysozyme did not correlate with those of serum potassium. However, the role of lysozyme as a cause of hypokalaemia cannot be investigated satisfactorily in AML since leukaemic patients develop proximal renal tubular dysfunction (Mir and Delamore, 1974) which may cause hypokalaemia, and many patients receive a wide variety of antibiotics such as gentamicin, polymyxin, etc., which have been known to cause hypokalaemia (Klastersky et al., 1973; Rodriguez, Green and Bodey, 1970) .
In order to settle the question whether raised lysozyme concentrations have any causal relationship with hypokalaemia, one would need to study the frequency of hypokalaemia in a disease in which raised concentrations of lysozyme occur but in which the abnormalities that are associated with AML and may cause hypokalaemia, are not found. Tuberculosis and sarcoidosis are 2 such conditions; raised serum lysozyme levels have been reported in both (Perillie, Khan and Finch, 1973; Pascual, Gee and Finch, 1973) 
Hypokalaemia
Seventeen of the 30 patients with AML developed hypokalaemia (serum K+< 3.5 mmol/l) at some stage during the course of their illness. Only 7 of these patients had raised serum lysozyme concentrations; one patient had lysozymuria but his serum lysozyme concentration was normal. Figure 1 shows correlation between concentrations of serum lysozyme and those of serum K+ in all the groups. As can be seen, none of the 50 patients with raised serum lysozyme concentrations in the tuberculosissarcoidosis group had hypokalaemia. Of the 5 leukaemic patients with serum K+ concentration of < 3 mmol/l, 3 had normal lysozyme concentrations.
Lysozymuria
Eleven patients in the tuberculosis group had lysozymuria (control < 1 ,ug/ml); 6 of these had normal serum lysozyme concentrations. None of the 18 patients with sarcoidosis had lysozymuria. Of the 30 patients with AML, 8 had lysozymuria; of these 8, 3 had normal serum lysozyme concentrations and 4 hypokalaemia.
Discussion
Serum lysozyme was elevated in a high proportion of patients with granulomatous infiltration of the glands. Patients with lymphoma were also studied, and a raised serum lysozyme concentration appeared to be a useful test in differentiating tuberculous or sarcoid involvement of hilar and mediastinal glands from lymphoproliferative disorders. This subject has been discussed elsewhere (Lodha and Mir, 1980) . The purpose of the present study was to investigate whether raised concentrations of serum lysozyme were associated with low serum K+ concentrations in sarcoidosis and tuberculosis. Hypokalaemia developed in 57% of the patients with AML and seemed to bear no definite relation to serum or urinary lysozyme concentration. In particular some patients in the tuberculous group had high concentrations of serum lysozyme but none of these developed hypokalaemia. Osserman and Lawlor (1966) put forward the suggestion that lysozyme may be responsible for hypokalaemia in AML, since raised concentrations of lysozyme were found in some leukaemic patients with hyperkaluria. However, lysozymuria has been found in various renal tubular disorders as a manifestation of the disease (Butler and Flyn, 1961; Prockop and Davidson, 1964) . Furthermore, leukaemic patients with normal serum lysozyme concentrations develop proximal renal tubular dysfunction (Mir and Delamore, 1974) . Hypokalaemia in AML occurs in well over 50% of patients and is probably multifactorial (Mir et al., 1975; Mir and Delamore, 1978) . Rosenthal, Maglio and Moloney (1972) showed that prolonged elevation of serum lysozyme in chloroleukaemic rats causes lysozymuria and hyperkaluria. Both tuberculosis and sarcoidosis are chronic diseases and serum lysozyme concentrations probably remain elevated longer in these diseases than they do in AML which is an acute disease with a rapid onset and, in most cases, runs an acute course. Some of the patients with glandular tuberculosis and sarcoidosis in this study were seen for longer than 18 months; elevated concentrations of lysozyme were observed but none of the patients developed hypokalaemia. This study provides further support for the thesis put forward by Mir et al. (1975) 
